Recent news
August 2010
World has “entered a highly promising era in HIV-prevention research,” new approaches needed to build on recent successes
August 12, 2010 -- Recent successes in HIV research “provide clear evidence we have entered a highly promising era in HIV-prevention research,” Alan Bernstein, executive director of the Global HIV Vaccine Enterprise, and Peter Piot—chair of the Global HIV Vaccine Enterprise and director of the London School of Hygiene and Tropical Medicine (LSHTM)—write in a Globe and Mail opinion piece. “Microbicides, vaccines, and other new approaches will one day join proven HIV-prevention strategies, including condoms, male circumcision and clean needles,” they write, adding, “How soon that day comes will depend on whether funders and the scientific community can develop the more collaborative approaches to HIV prevention research needed to address this fast-moving epidemic.”
According to Bernstein and Piot, new approaches are needed “to bring funders and scientists from around the world working together to advance HIV prevention and other major public-health goals.” They add that “HIV-prevention research requires systematic, strategic approaches that maximize the scientific value of public-private partnerships, minimize risk for industry, and permit the sharing of research findings and data.” In addition, the authors call for a “new spirit of global collaboration among funders, researchers, communities, local and national governments, and trial volunteers, as well as a new generation of HIV researchers, encouraged to enter this field by the conviction they can help end this epidemic.” See the link below for more information.
